Alberta Investment Management Corp Vertex Pharmaceuticals Inc Transaction History

Alberta Investment Management Corp

$10.2 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$314.42 - $351.91 $57,538 - $64,399	-183 Reduced 3.11%	5,700 $2.01 Million
Q1 2023 May 15, 2023	SELL	$283.23 - $323.1 $283,796 - $323,746	-1,002 Reduced 14.55%	5,883 $1.85 Million
Q4 2022 Feb 14, 2023	SELL	$285.76 - $321.48 $9.81 Million - $11 Million	-34,317 Reduced 83.29%	6,885 $1.99 Million
Q2 2022 Aug 15, 2022	SELL	$234.96 - $292.55 $11.7 Million - $14.6 Million	-49,998 Reduced 54.82%	41,202 $11.6 Million
Q1 2022 May 16, 2022	BUY	$221.42 - $260.97 $2.66 Million - $3.13 Million	12,000 Added 15.15%	91,200 $23.8 Million
Q4 2021 Feb 11, 2022	SELL	$177.01 - $223.45 $2.2 Million - $2.78 Million	-12,452 Reduced 13.59%	79,200 $17.4 Million
Q3 2021 Nov 15, 2021	SELL	$181.39 - $202.99 $890,624 - $996,680	-4,910 Reduced 5.08%	91,652 $16.6 Million
Q2 2021 Aug 16, 2021	SELL	$187.49 - $221.1 $1.02 Million - $1.21 Million	-5,463 Reduced 5.35%	96,562 $19.5 Million
Q1 2021 May 07, 2021	SELL	$207.02 - $241.31 $3.56 Million - $4.14 Million	-17,175 Reduced 14.41%	102,025 $21.9 Million
Q4 2020 Feb 16, 2021	BUY	$207.01 - $276.09 $13 Million - $17.3 Million	62,600 Added 110.6%	119,200 $28.2 Million
Q3 2020 Oct 26, 2020	BUY	$255.65 - $303.1 $4.17 Million - $4.94 Million	16,300 Added 40.45%	56,600 $15.4 Million
Q2 2020 Aug 11, 2020	BUY	$225.48 - $295.8 $8.52 Million - $11.2 Million	37,800 Added 1512.0%	40,300 $11.7 Million
Q1 2020 May 08, 2020	BUY	$199.77 - $247.81 $499,425 - $619,525	2,500 New	2,500 $595,000
Q3 2019 Oct 23, 2019	SELL	$166.23 - $187.09 $1.36 Million - $1.53 Million	-8,200 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$164.61 - $190.37 $954,738 - $1.1 Million	5,800 Added 241.67%	8,200 $1.5 Million
Q1 2019 May 15, 2019	BUY	$163.73 - $194.7 $392,952 - $467,280	2,400 New	2,400 $441,000
Q3 2018 Nov 16, 2018	SELL	$167.73 - $192.74 $2.05 Million - $2.35 Million	-12,200 Closed	0 $0
Q2 2018 Aug 15, 2018	BUY	$145.72 - $169.96 $1.28 Million - $1.5 Million	8,800 Added 258.82%	12,200 $2.07 Million
Q1 2018 May 16, 2018	SELL	$151.6 - $177.13 $727,680 - $850,224	-4,800 Reduced 58.54%	3,400 $554,000
Q4 2017 Feb 15, 2018	BUY	$137.28 - $155.55 $1.13 Million - $1.28 Million	8,200	8,200 $1.23 Million

Others Institutions Holding VRTX

# of Institutions

1,717

Shares Held

226M

Call Options Held

1.19M

Put Options Held

1.56M

Capital World Investors Los Angeles, CA

26.7M
Shares

$13.8 Billion
2.1% of portfolio
Vanguard Group Inc Valley Forge, PA

23M
Shares

$11.9 Billion
0.21% of portfolio
Black Rock Inc. New York, NY

21.3M
Shares

$11 Billion
0.23% of portfolio
State Street Corp Boston, MA

11.7M
Shares

$6.06 Billion
0.24% of portfolio
Capital Research Global Investors Los Angeles, CA

8.54M
Shares

$4.41 Billion
0.9% of portfolio

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $133B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alberta Investment Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Alberta Investment Management Corp with notifications on news.

Account